Group 1 - BYD reported August sales of 174,915 new energy vehicles, a year-on-year increase of 184.84% [1] - Cumulative sales from January to August reached 978,795 units, representing a year-on-year growth of 267.31% [1] - The company sold 5,092 new energy passenger vehicles overseas in August [1] Group 2 - Zhongke Electric's subsidiary plans to establish a joint venture with Chongqing Fudi for the production of anode materials, with a registered capital of 1 billion RMB [2] - Zhongke Electric's subsidiary will contribute 650 million RMB, while Chongqing Fudi will contribute 350 million RMB [2] Group 3 - Yuyuan Group intends to transfer 13% of its shares in Jinhuijiu for approximately 1.937 billion RMB, reducing its stake to 25% [3] - The company plans to further reduce its holdings by more than 5% within the next six months [3] Group 4 - Lizhu Group's recombinant COVID-19 fusion protein vaccine has been included in the emergency use for sequential booster immunization [4] Group 5 - Guanghui Energy plans to repurchase shares worth between 800 million and 1 billion RMB to support employee stock ownership plans [5] Group 6 - Cambrian has launched four cloud-based intelligent chips, although mass sales will require a longer time frame and initial technical service investments [7] Group 7 - LePu Medical has received approval from the China Securities Regulatory Commission for the issuance of Global Depositary Receipts (GDRs) and listing on the Swiss Stock Exchange [9] - The GDR issuance will correspond to no more than 180,458,875 new A-shares [9] Group 8 - Fushi Holdings' subsidiary has entered into an exclusive advertising agency cooperation with the Central Radio and Television Station's automotive channel for three years [10] Group 9 - Guangzhou Port's container throughput in August was 1.981 million TEUs, a year-on-year increase of 2.4% [11] - The total cargo throughput for August was 44.788 million tons, a decrease of 0.6% [11] Group 10 - Ningbo Port expects to complete a container throughput of 3.58 million TEUs in August, a year-on-year increase of 10.2% [12] - The total cargo throughput is projected to decline by 3.0% [12] Group 11 - Ming Tai Aluminum reported a 7% year-on-year decrease in aluminum plate and strip sales in August, while aluminum profile sales increased by 47% [13] Group 12 - Electric Power Investment plans to invest in multiple wind and solar projects, with total static investments of 1.585 billion RMB for wind and 538 million RMB for solar [14] Group 13 - Northeast Pharmaceutical has signed a cooperation agreement with MedAbome for the development of the MAb11-22.1 antibody project [19] Group 14 - New Five Feng plans to acquire equity in Tianxin Seed Industry and several other companies for a total price of approximately 2.208 billion RMB [26] Group 15 - Sumeida's subsidiary plans to transfer 100% equity of eight photovoltaic power station project companies, with an estimated transaction value of 657 million RMB [27] Group 16 - *ST Tongzhou intends to acquire 51% equity in Tongtaiwei, fulfilling the capital contribution obligation of 10.2 million RMB [29] Group 17 - Tianyin Holdings' subsidiary plans to invest 120 million RMB in Xundong Xintong to acquire 40% equity [30] Group 18 - Hainan Haiyao plans to publicly transfer 43% equity in Shanghai Lishengte to attract new investors [31] Group 19 - New Asia Process plans to transfer 7.76% of its shares to Xiangcai New Materials at a price of 5.274 RMB per share [32] Group 20 - Lanwei Medical plans to raise no more than 664 million RMB through a private placement for provincial laboratory construction projects [34] Group 21 - Lida New Materials plans to issue convertible bonds to raise no more than 300 million RMB for a new aluminum material project [35] Group 22 - Gekewei has successfully launched its 12-inch CIS integrated circuit project, achieving over 95% yield [51] Group 23 - Baijin Medical's tricuspid valve ring product has received registration approval [52] Group 24 - Shanghai Pharmaceuticals has received approval to initiate Phase I clinical trials for a recombinant anti-CD20 humanized monoclonal antibody [53] Group 25 - Junda Co. has increased the production capacity of its solar cell production base project from 8GW to 10GW [54]

Core Viewpoint - Cambridge Technology is facing scrutiny over its upcoming Hong Kong IPO due to concerns about the timing of its fundraising in relation to significant share reductions by major shareholders and inconsistencies in its financial data [1][11][12]. Financial Performance - Cambridge Technology reported fluctuating revenues and net profits from 2022 to 2024, with revenues of RMB 3.786 billion, RMB 3.087 billion, and RMB 3.652 billion, reflecting year-on-year growth rates of 29.66%, -18.46%, and 18.31% respectively [2][3]. - The net profits for the same period were RMB 171 million, RMB 95 million, and RMB 167 million, with year-on-year growth rates of 154.93%, -44.59%, and 75.42% respectively [2][3]. IPO Fundraising Purpose - The company plans to use the proceeds from the Hong Kong IPO to enhance production capacity for optical modules, broadband, and wireless solutions, as well as to improve R&D capabilities and supplement working capital [2][6]. - The specific amount to be raised has not yet been disclosed [2]. Previous Fundraising Issues - Cambridge Technology's previous fundraising projects have faced delays and changes, with the most significant project, the optical module project, experiencing multiple extensions and currently being integrated into a new project [3][4][5]. - The optical module project was initially set to be completed in one year but has now been extended to five years without generating expected benefits [4][5]. Supplier Data Discrepancies - There are notable discrepancies between the procurement data reported in the company's annual report and the Hong Kong IPO prospectus, raising questions about the reliability of the financial data [8][9]. - For instance, the procurement amounts for the top five suppliers differ significantly between the two documents, with the annual report showing lower totals compared to the IPO prospectus [8][9]. Shareholder Actions - The controlling shareholders plan to reduce their holdings by up to 3% through block trades and open market transactions, which has raised investor concerns about the timing of the IPO and the potential implications for company governance [11][12][13]. - The company has stated that the reduction in shareholding is based on the shareholders' business needs and is not directly related to the IPO [12][13].

Core Viewpoint - Cambridge Technology (603083.SH) has successfully commenced bulk shipments of its 800G optical module products, indicating a significant advancement in its product offerings and market position [1] Group 1: Product Development - The company's overseas R&D team completed the first-generation 1.6T module prototype development in 2024 and successfully conducted a live demonstration at the 2024 OFC, garnering widespread attention in the industry [1] - In 2025, the overseas R&D team plans to continue developing multiple 200G/Lane 1.6T optical module products based on 3nm DSP technology, with plans to send samples to customers [1]

Core Viewpoint - A number of companies have announced shareholder reduction plans following significant stock price increases, particularly among popular concept stocks, indicating a potential shift in market sentiment and investor behavior [1][4]. Group 1: Shareholder Reduction Plans - On May 13, over ten companies, including Gaozheng Mingbao, Haichuang Pharmaceutical, and Cambridge Technology, disclosed shareholder reduction plans, with many shareholders planning to reduce their stakes by over 2% [1][2]. - Cambridge Technology's shareholders plan to reduce a total of 804.12 million shares and 186.27 million shares, representing 3% of the company's shares, with a total reduction amounting to approximately 3.95 billion yuan based on the latest closing price [2]. - Other companies like Gaozheng Mingbao and New Strong Link also reported significant planned reductions, with amounts exceeding 2 billion yuan [2][3]. Group 2: Stock Performance - Since April 8, the Shanghai and Shenzhen markets have experienced a significant rally, with the Shanghai Composite Index rebounding by 9.93% and the Shenzhen Component Index rising by 15.27% [4]. - Companies like Haichuang Pharmaceutical, Cambridge Technology, and Gaozheng Mingbao have seen stock price increases of over 19% in May, reaching new highs for the year [4][5]. - Despite substantial stock price increases, some companies, such as Haichuang Pharmaceutical, continue to report poor financial performance, with ongoing losses and no revenue generation [5][6]. Group 3: Historical Context of Reductions - Several companies have experienced multiple rounds of shareholder reductions prior to the recent announcements, indicating a trend of ongoing divestment by major shareholders [6]. - For instance, Haichuang Pharmaceutical's second-largest shareholder recently completed a reduction of 334.42 million shares, while Cambridge Technology has faced frequent reductions from its shareholders since last year [6][7]. - If the current reduction plans are fully executed, some shareholders will fall below the 5% threshold, eliminating the need for future disclosure of further reductions [7].

证券代码：603083 证券简称：剑桥科技 公告编号：临2025-027 上海剑桥科技股份有限公司 控股股东及其一致行动人减持股份计划公告 公司 IPO 前股东上海康令科技合伙企业（有限合伙）（以下简称"康令科 技"），在本次减持计划实施前持有公司股份 7,451,076 股，占公司股份总数的 2.78%。上述股份来源于 2017 年度、2018 年度和 2019 年度利润分配暨资本公积 转增的股份，且已于 2020 年 11 月 10 日解除限售上市流通。 减持计划的主要内容 CIG 开曼和康令科技计划在履行减持股份预先披露义务的十五个交易日后， 通过大宗交易方式和集中竞价交易方式减持公司股份的数量总计不超过 8,041,254 股，占公司股份总数的 3.00%。其中，在任意 90 日内通过大宗交易方 式减持公司股份合计不超过 5,360,836 股，占公司股份总数的 2.00%，且大宗交 易受让方在受让后 6 个月内不转让所受让的股份；在任意 90 日内通过集中竞价 交易方式减持公司股份合计不超过 2,680,418 股，占公司股份总数的 1.00%。减 持价格按照市场价格确定，且不低于公司股票的发行价（ ...

智通财经5月13日电，剑桥科技(603083.SH)公告称，Cambridge Industries Company Limited和康令科技计 划通过大宗交易和集中竞价方式减持不超过8,041,254股，占公司总股本的3.00%。 剑桥科技：股东计划减持不超过3.00%公司股份 ...

Group 1 - Major market indices opened higher on May 12, with the Shanghai Composite Index rising by 0.33% and the ChiNext Index increasing by 1.55% [1] - The defense and military industry stocks experienced significant growth, with the defense and military index up by 4.8%, leading the industry gainers [1] - Concepts such as China Shipbuilding, Chengfei, domestic aircraft carriers, military informationization, and civil-military integration saw substantial increases [1] Group 2 - In the past five trading days (April 30 to May 9), 30 stocks were reported to have significant shareholder increases, totaling 1.87 billion shares and an aggregate increase amounting to 32.63 billion yuan [2] - The stock with the highest increase in amount was BYD, with a total increase of 3.012 million shares and an increase amount of 1.077 billion yuan [2] - Other notable increases included Dongfang Shenghong with 66.1122 million shares and an increase amount of 589 million yuan, and Shaanxi Energy with an increase amount of 337 million yuan [2] Group 3 - As of May 9, the total market financing balance was 1.79 trillion yuan, a decrease of 4.7 billion yuan from the previous trading day [3] - A total of 256 stocks had net financing purchases exceeding 10 million yuan, with 25 stocks having net purchases over 50 million yuan [3] - The top net purchase was for AVIC Chengfei at 187 million yuan, followed by Wanxiang Qianchao and SMIC with net purchases of 180 million yuan and 175 million yuan, respectively [3] Group 4 - On May 12, 14 companies announced shareholder reduction plans, with notable companies including Keli Ke, Jingwei Huikai, Hualan Biological Engineering, and Huili Pharmaceutical [4]

Group 1 - The main point of the news is that there was a net outflow of 1.878 billion yuan in the stock market today, with the ChiNext board experiencing a net outflow of 397 million yuan, while the CSI 300 index saw a net inflow of 3.007 billion yuan [1] - Among the 11 industries with net inflows, the communication industry led with a net inflow of 2.433 billion yuan, followed by the electric equipment, media, and retail industries, each exceeding 1 billion yuan [1] - The chemical sector saw significant net outflows, with the leading company experiencing a net outflow of 884 million yuan, indicating a downward trend in the chemical industry [4][5] Group 2 - Contemporary Amperex Technology Co., Ltd. (CATL) saw a 2.5% increase in stock price with a net inflow of 790 million yuan, following the announcement of its share buyback progress [2][3] - New Yisheng, a CPO concept stock, had a net inflow of 718 million yuan, reflecting strong market performance in the CPO sector, which is projected to grow significantly in the coming years [2] - The chemical leader Hongbaoli faced a substantial net outflow of 883 million yuan, with the stock price dropping by 9.5%, indicating investor concerns in the chemical sector [4][5] Group 3 - The military industry continued to show strong performance, with several stocks hitting the daily limit up, indicating robust investor interest in this sector [6] - A total of 22 stocks had net inflows exceeding 30 million yuan at the end of the trading day, with three stocks exceeding 80 million yuan, highlighting active trading in specific sectors [6][7] - The tail end of the trading day saw a net inflow of 776 million yuan across the market, with the ChiNext board contributing 246 million yuan to this total [8]

Group 1 - F5G concept index increased by 2.35%, ranking 10th among concept sectors, with 31 stocks rising, including Cambridge Technology hitting the daily limit [1][2] - Leading gainers in the F5G sector include Zhongji Xuchuang, Dekeli, and Taichuang, with increases of 11.36%, 7.47%, and 5.95% respectively [1][2] - Major declines were seen in Pingzhi Information, Shanghai Port Group, and Yihua Co., with decreases of 2.04%, 0.54%, and 0.34% respectively [1][2] Group 2 - The F5G sector attracted a net inflow of 1.125 billion yuan, with 23 stocks receiving net inflows, and 5 stocks exceeding 30 million yuan in net inflow [2][3] - Zhongji Xuchuang led the net inflow with 519 million yuan, followed by Cambridge Technology and Taichuang with 360 million yuan and 145 million yuan respectively [2][3] Group 3 - In terms of net inflow ratio, Cambridge Technology, Zhaochi Co., and Xingwang Ruijie had the highest ratios at 24.53%, 10.44%, and 8.45% respectively [3][4] - The top stocks in the F5G sector by net inflow include Zhongji Xuchuang, Cambridge Technology, and Taichuang, with respective daily turnover rates of 9.02%, 14.75%, and 14.47% [3][4] Group 4 - Notable declines in the F5G sector were observed in Pingzhi Information, which fell by 2.04%, and other companies like Chunyuan Electric and Bochuang Technology, which also experienced negative net inflows [5]

证券代码：603083 证券简称：剑桥科技 公告编号：临 2025-026 上海剑桥科技股份有限公司 关于参加 2025 年上海辖区上市公司年报集体业绩说明会的公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 5 月 15 日（周四）15:00-16:30 会议召开地点：上海证券交易所上证路演中心（网址：https://roadshow. sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 5 月 9 日（周五）至 5 月 14 日（周三）16:00 前登录 上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 investor@cigte ch.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 为便于广大投资者更全面深入地了解公司经营成果、财务状况，上海剑桥科 技股份有限公司（以下简称"公司"）计划于 2025 年 5 月 15 日（周四）15:00-16:30 参加"2025 年上海辖区上市公司年报集体业绩 ...